Skip to main content

Table 1 Details of included articles

From: Critically appraised topic for the most effective and safe treatment for canine generalised demodicosis

Reference

Year

Authors

Title

[4]

1983

S.D. Folz et al

Chemotherapeutic treatment of naturally acquired generalized demodicosis.

[5]

1995

W.H. Miller et al

Clinical efficacy of increased dosages of milbemycin oxime for treatment of generalized demodicosis in adult dogs.

[6]

1995

Z. Ristic et al

Ivermectin for treatment of generalized demodicosis in dogs.

[7]

2003

B.R. Holm

Efficacy of milbemycin oxime in the treatment of canine generalized demodicosis: a retrospective study of 99 dogs (1995–2000)

[8]

2005

J. Heine et al

Evaluation of the efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of generalized demodicosis in dogs: results of a European field study.

[9]

2006

E.H. Delayte et al

Eficàcia das lactonas macrocìclicas sistemicas (ivermectina e moxidectina) na terapia da demodicidose canina generalizada.

[10]

2007

L.J. Fourie et al

Efficacy of a novel formulation of metaflumizone plus amitraz for the treatment of demodectic mange in dogs.

[11]

2009

L.J. Fourie et al

Comparative efficacy and safety of two treatment regimens with a topically applied combination of imidacloprid and moxidectin (Advocate) against generalised demodicosis in dogs.

[12]

2010

Murayama et al

Efficacy of weekly oral doramectin treatment in canine demodicosis.

[13]

2000

R. Wagner et al

Field efficacy of moxidectin in dogs and rabbits naturally infested with Sarcoptes spp., Demodex spp. and Psoroptes spp. mites.

[14]

2013

L.J. Fourie et al

Efficacy of a topical application of Certifect (fipronil 6.26% w/v, amitraz 7.48% w/v, (S)-methoprene 5,63% w/v) for the treatment of canine generalized demodicosis.

[15]

2015

J.H.C. Hutt

Treatment of canine generalized demodicosis using weekly injections of doramectin: 232 cases in the USA (2002–2012).

[16]

2009

T.E. Paterson et al

Treatment of canine-generalized demodicosis: a blind, randomized clinical trial comparing the efficacy of Advocate (Bayer Animal Health) with ivermectin.

[17]

2014

T.E. Paterson et al

Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin + 10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.

[18]

2015

L.J. Fourie et al

Efficacy of orally administered fluralaner (Bravecto) or topically applied imidacloprid/moxidectin (Advocate) against generalized demodicosis in dogs.

19

2016

R.H. Six et al

Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis.

[20]

2016

F. Beugnet et al

Efficacy of oral afoxolaner for the treatment of canine generalised demodicosis

[21]

2017

D.E Snyder et al

Efficacy of lotilaner (Credelioâ„¢), a novel oral isoxazoline against naturally occurring mange mite infestations in dogs caused by Demodex spp.

[22]

2018

A.M.Cordero et al

Doramectin in the treatment of generalized demodicosis.

[23]

2018

C. Becskei et al

Efficacy and safety of sarolaner against generalized demodicosis in dogs in European countries: a non-inferiority study.

[24]

2018

L.Duangkaew et al

A field trial in Thailand of the efficacy of oral fluralaner for the treatment of dogs with generalized demodicosis.